Results 81 to 90 of about 12,305,089 (195)
In this study, we assessed the impact of commercially available polymyxin B against VRP-034 (novel formulation of polymyxin B) using a validated in vitro human renal model, aProximateTM. Freshly isolated primary proximal tubule cells (PTCs) were cultured
Keith Pye +4 more
doaj +1 more source
إنتاج المضاد الحيوي B Polymyxin من البكتريا العصوية Bacillus sp.
عزل المضاد الحيوي Polymyxin الفعال ذو الطيف الواسع من الجرثومة العصويةBacillus sp. ، بشكل مسحوق دهني ابيض باهت اللون. درست الصفات الفيزيائية والكيميائية للمضاد الحيوي المستخلص باستخدام تقنية كروماتوغرافيا الطبقة الرقيقة (TLC) وطيف الأشعة تحت الحمراء
صالح, أفروديت عبد الرزاق +2 more
core
Revisiting Polymyxin B: Pharmacokinetics, Biodistribution and Mechanism(s) of Intrarenal Transport [PDF]
Objectives: Despite dose-limiting nephrotoxic potentials, polymyxin B has re-emerged as the last line of therapy against multidrug-resistant Gram-negative bacterial infections.
Manchandani, Pooja
core
Polymyxin B: Controlled biosynthesis.
L, Withander, H, Heding
openaire +3 more sources
Subconjunctival Injection of Polymyxin B [PDF]
openaire +2 more sources
Comparative Neurotoxicity of Polymyxin B and Colistin in Patients With Cancer. [PDF]
Aitken SL +3 more
europepmc +1 more source
Polymyxin B-Associated Muscle Injury: A Case Report. [PDF]
Lei W +5 more
europepmc +1 more source
Weight-based polymyxin B dosing for mortality and nephrotoxicity: an exploratory dose-response study. [PDF]
Pan SC +4 more
europepmc +1 more source

